Literature DB >> 16887812

Effects of oncogenic mutations and DNA response elements on the binding of p53 to p53-binding protein 2 (53BP2).

Henning Tidow1, Dmitry B Veprintsev, Stefan M V Freund, Alan R Fersht.   

Abstract

The tumor suppressor p53 is frequently mutated in human cancers. Upon activation it can induce cell cycle arrest or apoptosis. ASPP2 can specifically stimulate the apoptotic function of p53 but not cell cycle arrest, but the mechanism of enhancing the activation of pro-apoptotic genes over cell cycle arrest genes remains unknown. In this study, we analyzed the binding of 53BP2 (p53-binding protein 2, the C-terminal domain of ASPP2) to p53 core domain and various mutants using biophysical techniques. We found that several p53 core domain mutations (R181E, G245S, R249S, R273H) have different effects on the binding of DNA response elements and 53BP2. Further, we investigated the existence of a ternary complex consisting of 53BP2, p53, and DNA response elements to gain insight into the specific pro-apoptotic activation of p53. We found that binding of 53BP2 and DNA to p53 is mutually exclusive in the case of GADD45, p21, Bax, and PIG3. Both pro-apoptotic and non-apoptotic response elements were competed off p53 by 53BP2 with no indication of a ternary complex.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16887812     DOI: 10.1074/jbc.M604725200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Insight into the structural basis of pro- and antiapoptotic p53 modulation by ASPP proteins.

Authors:  Jinwoo Ahn; In-Ja L Byeon; Chang-Hyeock Byeon; Angela M Gronenborn
Journal:  J Biol Chem       Date:  2009-02-26       Impact factor: 5.157

2.  Ultraslow oligomerization equilibria of p53 and its implications.

Authors:  Eviatar Natan; Daniel Hirschberg; Nina Morgner; Carol V Robinson; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-10       Impact factor: 11.205

3.  Telethonin deficiency is associated with maladaptation to biomechanical stress in the mammalian heart.

Authors:  Ralph Knöll; Wolfgang A Linke; Peijian Zou; Snjezana Miocic; Sawa Kostin; Byambajav Buyandelger; Ching-Hsin Ku; Stefan Neef; Monika Bug; Katrin Schäfer; Gudrun Knöll; Leanne E Felkin; Johannes Wessels; Karl Toischer; Franz Hagn; Horst Kessler; Michael Didié; Thomas Quentin; Lars S Maier; Nils Teucher; Bernhard Unsöld; Albrecht Schmidt; Emma J Birks; Sylvia Gunkel; Patrick Lang; Henk Granzier; Wolfram-Hubertus Zimmermann; Loren J Field; Georgine Faulkner; Matthias Dobbelstein; Paul J R Barton; Michael Sattler; Matthias Wilmanns; Kenneth R Chien
Journal:  Circ Res       Date:  2011-07-28       Impact factor: 17.367

4.  An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells.

Authors:  Hsiao-Sheng Liu; Pei-Yin Hsu; Ming-Derg Lai; Hong-Yi Chang; Chung-Liang Ho; Hong-Lin Cheng; Hsing-Ta Chen; Yan-Ju Lin; Tsung-Jung Wu; Tzong-Shin Tzai; Nan-Haw Chow
Journal:  Carcinogenesis       Date:  2010-05-24       Impact factor: 4.944

5.  Structural basis for understanding oncogenic p53 mutations and designing rescue drugs.

Authors:  Andreas C Joerger; Hwee Ching Ang; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2006-10-02       Impact factor: 11.205

6.  Quaternary structures of tumor suppressor p53 and a specific p53 DNA complex.

Authors:  Henning Tidow; Roberto Melero; Efstratios Mylonas; Stefan M V Freund; J Guenter Grossmann; José María Carazo; Dmitri I Svergun; Mikel Valle; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-09       Impact factor: 11.205

7.  iASPP is over-expressed in human non-small cell lung cancer and regulates the proliferation of lung cancer cells through a p53 associated pathway.

Authors:  Jinfeng Chen; Fei Xie; Lijian Zhang; Wen G Jiang
Journal:  BMC Cancer       Date:  2010-12-30       Impact factor: 4.430

8.  2-Sulfonylpyrimidines: Mild alkylating agents with anticancer activity toward p53-compromised cells.

Authors:  Matthias R Bauer; Andreas C Joerger; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-22       Impact factor: 11.205

9.  Structural basis for ASPP2 recognition by the tumor suppressor p73.

Authors:  Peter Canning; Frank von Delft; Alex N Bullock
Journal:  J Mol Biol       Date:  2012-08-20       Impact factor: 5.469

10.  Regulation of ASPP2 interaction with p53 core domain by an intramolecular autoinhibitory mechanism.

Authors:  Shahar Rotem-Bamberger; Chen Katz; Assaf Friedler
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.